Senti Biosciences Granted US Patent #12005081 For "Chimeric Receptors And Methods Of Use For Acute Myeloid Leukemia Cancer Antigen Targets" Today
Senti Biosciences Granted US Patent #12005081 For "Chimeric Receptors And Methods Of Use For Acute Myeloid Leukemia Cancer Antigen Targets" Today
Senti Biosciences今日獲授權的美國專利號爲#12005081，用於急性髓性白血病癌抗原靶標的嵌合受體及其使用方法
Senti Biosciences Granted US Patent #12005081 For "Chimeric Receptors And Methods Of Use For Acute Myeloid Leukemia Cancer Antigen Targets" Today
Senti Biosciences今天被授予了美國專利＃12005081，用於“嵌合受體和治療急性髓性白血病癌抗原靶標的方法”。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。